Navigation Links
CNBC Features MMJ International Holdings on FDA, DEA Approved Marijuana Studies
Date:7/12/2019

Ted Danson on CNBC will be hosting an interview of the MMJ International Holdings executives focusing on scientific research for the advancement of medical marijuana-based pharmaceuticals in an upcoming episode, scheduled to broadcast July 14, 2019 @ 1:30p.m. on CNBC. Check your local listings for more information.

With two investigational new drug applications already accepted by the FDA, MMJ International Holdings (MMJIH) is working to bring relief to patients suffering from Multiple Sclerosis and Huntington’s disease. This segment of advancements TV will focus on the science of medical cannabis and how our development of a pharmaceutical medicine of THC and cannabidiol, or CBD, is going to help people manage symptoms associated with Multiple Sclerosis, Huntington’s and other like neurological diseases.

“MMJ is excited to be part of this breakthrough episode of Advancements TV,” said CEO of MMJ International Holdings, Duane Boise. He continued, “We would like to commend the series on its vision and foresight in recognizing the need to educate audiences about the science of medical cannabis. MMJIH has always been an advocate for creating awareness about the value of marijuana-based pharmaceuticals. We believe that this industry is about to undergo a massive transformation and we are honored to be leader in the evolution of it.”

“MMJIH truly cares about helping people,” said Tim Moynahan, MMJIH Chairman “Using innovative technology, MMJ is helping to drastically cut drug development costs to obtain approval for an insurance reimbursable medicine. Patients are in need of a safe and effective marijuana-based pharmaceuticals to manage their unmet medical needs.”

About MMJIH:
MMJ International Holdings is dedicated to advancing the science of medical Cannabis. Having been awarded the FDA Orphan Designation, MMJIH is intent on bringing relief to patients around the world with its innovative and well FDA researched medical products. MMJ’s journey continues to prove the efficacy of cannabis as an FDA approved medicine while its unique scientific approach further distinguishes MMJ from others in the industry.

For more information, visit: http://www.mmjih.com.

Read the full story at https://www.prweb.com/releases/cnbc_features_mmj_international_holdings_on_fda_dea_approved_marijuana_studies/prweb16434134.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. NEPC’s February Education Interview of the Month Features Discussion of Teachers as Brand Ambassadors
2. Clearskincare Cites Flexible Reporting Features For Switch to Zenoti
3. "Information Matrix", with Laurence Fishburne, Features a New Piece on Preventative Medicine
4. Provista Launches One-Stop Web Destination For Industry News, Features And Information
5. Nature Biotechnology Features ReadCoor as a 2016 Leading Spinout
6. Data4Cures AI-Powered Biomedical Intelligence Cloud Features New Tools for Multidimensional Disease Mapping and Immune-Oncology Research
7. Synthetic Biologics Confirms Key Features of Pivotal Phase 2b/3 Trial of SYN-010 Pursuant to Consultations with FDA
8. CPhI SEA -- the leading pharma event in South East Asia - adds 6 new features
9. 2016 Continua Design Guidelines Include New Features For Simple Connectivity Of Personal Connected Health Devices
10. Excipient & Dosage Market Among Main Features of CPhI China 2016
11. CBS News Features Dr. Ashraf Hanna Describing How IV Ketamine is Successfully Treating Fibromyalgia Pain Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2019)... ... August 22, 2019 , ... The American Society for Clinical Pathology ... leadership qualities that are making an impact on pathology and laboratory medicine. This year’s ... like these alums, they will continue to advance into even more prominent positions and ...
(Date:8/23/2019)... (PRWEB) , ... August 22, 2019 , ... ... years, but fasting shouldn’t be dismissed as a fad. In a study published ... inflammatory diseases without affecting the immune system’s response to acute infections. , ...
(Date:8/23/2019)... ... August 23, 2019 , ... ... master’s in healthcare informatics has been ranked sixth in the nation by ... worlds of medicine and technology by combining their expertise in data management, ...
Breaking Medicine Technology:
(Date:8/21/2019)... ... ... Photoprotective Technologies (PPT) has just received US patent 10/357,124 for its HEV Melanin ... such as creams or makeup and is distributed by Vantage Specialty Ingredients under a ... from blue light as well as UV. , Melanin - Nature’s Sunscreen., Melanin ...
(Date:8/19/2019)... ... August 19, 2019 , ... AJG Packaging, ... announced the availability of resealable single-dose vials for a multitude of applications. The ... consists of five resealable breakaway vials and are available in either polyethylene or ...
(Date:8/19/2019)... ... August 19, 2019 , ... Professional Enrollment ... Antonio, Texas, proudly announces they have ranked #3056 on the 2019 Inc. 5000 ... a unique look at the most successful companies within the American economy's most ...
(Date:8/17/2019)... , ... August 17, 2019 , ... ... are receiving free dental care services today under a program sponsored by United ... Arlington and are proud to work alongside them to make these services available ...
(Date:8/16/2019)... ... August 16, 2019 , ... The clinical trial supply chain landscape is ... , Join Just In Time Manufacturing Solutions Manager at Almac Clinical Services ... at 11am EDT (4pm BST/UK) on a journey through time as it relates to ...
Breaking Medicine News(10 mins):